atopica logo

ATOPICA® (cyclosporine capsules) USP MODIFIED

Bronchi-Shield® ORAL

Clomicalm Logo 4C 2016

Clomicalm® (clomipramine hydrochloride)

Comfortis Logo

Comfortis® (spinosad)

Credelio® (lotilaner)

Deramaxx logo

Deramaxx® (deracoxib)

Duramune Lyme

Entyce® (capromorelin oral solution)

Galliprant Logo

Galliprant® (grapiprant tablets)

Interceptor® (milbemycin oxime)

Interceptor Plus Logo

Interceptor® Plus (milbemycin oxime/praziquantel)

Nocita® (bupivacaine liposome injectable suspension)

Onsior logo

Onsior® Tablets for Dogs (robenacoxib)

onsior logo

Onsior® Injection (robenacoxib)


Parastar® for Dogs

ParastarPLUS Logo

Parastar® Plus (fipronil/cyphenothrin)

Percorten-V Logo

Percorten®-V (desoxycorticosterone pivalate injectable suspension)

Placeholder until correct image


Surolan Logo

Surolan® (miconazole nitrate, polymyxin B sulfate, prednisolone acetate)

Tanovea®-CA1 (rabacfosadine for injection)

Trifexis logo

Trifexis® (spinosad + milbemycin oxime)

Ultra Duramune

Vetspon logo


Zobuxa logo

Zobuxa® (enrofloxacin)

Onsior logo
Onsior® Tablets for Dogs (robenacoxib)

Help get them from hospital to home comfortably

With demonstrated efficacy for use up to a maximum of 3 days, Onsior should be your NSAID of choice for spay/neuter pain relief.

Onsior is an excellent option because it's:

  • rapidly absorbed, persists at site of inflammation and is rapidly cleared from the bloodstream*1
  • small, flavored tablets with once-daily dosing for up to a maximum of 3 days
  • well-suited for spays and neuters

*clinical relevance unknown

Click here to learn more


Onsior® (robenacoxib) Tablets for Dogs are approved for the control of postoperative pain and inflammation associated with soft tissue surgery in dogs ≥ 5.5 lbs (2.5 kg) and ≥ 4 months of age; for up to a maximum of 3 days.

Important Safety Information

Do not use in dogs that have a hypersensitivity to robenacoxib or known intolerance to NSAIDs. Not for use in humans. Keep this and all drugs out of reach of children and pets. Do not use for more than 3 days. Serious adverse events have been reported with long term use in dogs. All dogs should undergo a thorough history and exam before initiation of NSAID therapy. Appropriate testing should be conducted prior to administration of an NSAID. Owners should be advised to observe for signs of potential drug toxicity. Stop administration of ONSIOR if the dog experiences inappetence, vomiting or lethargy. Safe use has not been evaluated in dogs younger than 4 months of age, dogs used for breeding, or in pregnant or lactating dogs. Do not administer in conjunction with any other NSAID or corticosteroid.

Onsior Tablets are for oral use in dogs only. Store out of reach of dogs and other pets in a secure location. Do not use in cats. Cats cannot be accurately dosed with the tablet sizes intended to be used in dogs. Dogs should weigh at least 5.5 lbs. The most commonly reported adverse reactions were diarrhea, vomiting, and decreased appetite. Please see the product insert for full prescribing information.

Onsior is a trademark of Elanco or its affiliates.

1 Silber, H., Burgener, C., Letellier, I., et al. 2010. “Population pharmacokinetic analysis of blood and joint fluid concentrations of robenacoxib from healthy dogs and dogs with osteoarthritis.” Pharm. Res. 27.12: 2633-2645.